FibroGen Inc - Company Profile
Powered by 
All the data and insights you need on FibroGen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date FibroGen Inc Strategy Report
- Understand FibroGen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, develops, and commercializes novel medicines for addressing the unmet medical needs of anemia, fibrotic disease, and cancer. Its products and pipeline are built on connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. The company reports its operations under single business segment that comprises of the discovery, development, and commercialization of novel medicines for the treatment of serious unmet medical needs. The company reports revenue from three streams: License, Development and Other, and Products revenue.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
FirbroGen’s research and development are focused on three areas of expertise: HIF biology, 2-oxoglutarate enzymology, and CTGF biology. It also focuses on research and development activities in other therapeutic areas such as Oncology, Immunology, Fibrosis. The company’s research and development expenses were US$296.8 million, which is 210.9% of total revenue. The company has its research and development facility located in San Franscisco, California.
Other Break-up
Overview
Consists of revenue from co-development and other development related services.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises commercial-grade API sales to Astellas, AstraZeneca for commercial validation for roxadusta.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises upfront payments, non-refundable license payments, amounts allocated pursuant to the standalone selling price method from other consideration received. License revenue are recognized under collaboration agreements with AstraZeneca and Astellas.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Consists of the revenue from Price adjustments, Contractual sales rebate, Non-key account listing awards, Other discounts and sales returns.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer